Concepts (178)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Multifactorial Inheritance | 3 | 2015 | 15 | 1.480 |
Why?
|
| Body Height | 4 | 2015 | 102 | 1.180 |
Why?
|
| Pluripotent Stem Cells | 1 | 2023 | 63 | 0.920 |
Why?
|
| Genome-Wide Association Study | 5 | 2015 | 286 | 0.910 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2023 | 98 | 0.880 |
Why?
|
| Phenotype | 7 | 2023 | 962 | 0.870 |
Why?
|
| Whole Genome Sequencing | 1 | 2018 | 46 | 0.660 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2018 | 243 | 0.630 |
Why?
|
| Tissue Donors | 1 | 2018 | 124 | 0.620 |
Why?
|
| Genetic Vectors | 1 | 2021 | 653 | 0.550 |
Why?
|
| Dependovirus | 1 | 2021 | 530 | 0.540 |
Why?
|
| B-Lymphocytes | 1 | 2018 | 522 | 0.530 |
Why?
|
| CRISPR-Cas Systems | 4 | 2023 | 302 | 0.510 |
Why?
|
| Colitis, Ulcerative | 1 | 2014 | 62 | 0.470 |
Why?
|
| Crohn Disease | 1 | 2014 | 86 | 0.460 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2023 | 404 | 0.420 |
Why?
|
| Algorithms | 3 | 2023 | 896 | 0.390 |
Why?
|
| Alleles | 1 | 2011 | 397 | 0.380 |
Why?
|
| Genome, Human | 3 | 2018 | 211 | 0.310 |
Why?
|
| Autism Spectrum Disorder | 2 | 2022 | 161 | 0.300 |
Why?
|
| Organoids | 2 | 2023 | 25 | 0.290 |
Why?
|
| Genetic Variation | 3 | 2018 | 332 | 0.280 |
Why?
|
| Quantitative Trait, Heritable | 2 | 2017 | 27 | 0.260 |
Why?
|
| Hyaluronan Receptors | 2 | 2015 | 35 | 0.250 |
Why?
|
| Genes, Immunoglobulin | 1 | 2023 | 31 | 0.240 |
Why?
|
| Databases, Genetic | 2 | 2017 | 77 | 0.240 |
Why?
|
| Cohort Studies | 3 | 2017 | 2123 | 0.200 |
Why?
|
| Mitochondria | 1 | 2023 | 303 | 0.190 |
Why?
|
| Swine | 1 | 2021 | 296 | 0.190 |
Why?
|
| Intellectual Disability | 1 | 2022 | 153 | 0.190 |
Why?
|
| Systems Biology | 2 | 2010 | 30 | 0.190 |
Why?
|
| Humans | 18 | 2023 | 50631 | 0.190 |
Why?
|
| Databases, Protein | 2 | 2010 | 43 | 0.190 |
Why?
|
| Autistic Disorder | 1 | 2022 | 154 | 0.180 |
Why?
|
| Data Mining | 2 | 2010 | 41 | 0.180 |
Why?
|
| Gene Editing | 1 | 2023 | 264 | 0.180 |
Why?
|
| Cell Line | 1 | 2023 | 1921 | 0.170 |
Why?
|
| Gene Transfer Techniques | 1 | 2021 | 260 | 0.170 |
Why?
|
| DNA, Fungal | 1 | 2018 | 57 | 0.170 |
Why?
|
| Sample Size | 1 | 2018 | 55 | 0.160 |
Why?
|
| Gene Library | 1 | 2018 | 94 | 0.160 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2014 | 639 | 0.160 |
Why?
|
| Geography | 1 | 2017 | 33 | 0.160 |
Why?
|
| Disease | 1 | 2017 | 25 | 0.150 |
Why?
|
| Mutation, Missense | 1 | 2017 | 166 | 0.150 |
Why?
|
| Obesity | 2 | 2014 | 1139 | 0.140 |
Why?
|
| Point Mutation | 2 | 2018 | 150 | 0.140 |
Why?
|
| Gene Silencing | 1 | 2018 | 347 | 0.140 |
Why?
|
| F-Box Proteins | 1 | 2015 | 16 | 0.140 |
Why?
|
| Computer Simulation | 1 | 2018 | 428 | 0.140 |
Why?
|
| Gene Frequency | 2 | 2014 | 115 | 0.140 |
Why?
|
| Leg Bones | 1 | 2015 | 2 | 0.140 |
Why?
|
| Drug Resistance, Multiple | 1 | 2015 | 32 | 0.140 |
Why?
|
| Immunity, Innate | 1 | 2021 | 707 | 0.140 |
Why?
|
| Homozygote | 1 | 2015 | 104 | 0.130 |
Why?
|
| Ubiquitination | 1 | 2015 | 93 | 0.130 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2017 | 550 | 0.130 |
Why?
|
| Odds Ratio | 2 | 2014 | 764 | 0.130 |
Why?
|
| Genetic Therapy | 1 | 2021 | 569 | 0.130 |
Why?
|
| Group II Chaperonins | 1 | 2014 | 2 | 0.130 |
Why?
|
| Genes, Recessive | 1 | 2014 | 49 | 0.130 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2015 | 161 | 0.130 |
Why?
|
| Albuminuria | 1 | 2014 | 18 | 0.130 |
Why?
|
| Chromosome Mapping | 1 | 2015 | 266 | 0.120 |
Why?
|
| Proteins | 2 | 2010 | 700 | 0.120 |
Why?
|
| Female | 7 | 2017 | 26610 | 0.120 |
Why?
|
| Diabetic Nephropathies | 1 | 2014 | 38 | 0.120 |
Why?
|
| Models, Genetic | 1 | 2014 | 244 | 0.120 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2018 | 519 | 0.120 |
Why?
|
| Male | 5 | 2017 | 23330 | 0.120 |
Why?
|
| Risk | 1 | 2014 | 358 | 0.120 |
Why?
|
| Growth Plate | 1 | 2012 | 13 | 0.110 |
Why?
|
| Kidney Failure, Chronic | 1 | 2014 | 159 | 0.110 |
Why?
|
| Periventricular Nodular Heterotopia | 1 | 2012 | 2 | 0.110 |
Why?
|
| Response Elements | 1 | 2012 | 36 | 0.110 |
Why?
|
| Models, Statistical | 1 | 2014 | 295 | 0.110 |
Why?
|
| Contractile Proteins | 1 | 2012 | 13 | 0.110 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2012 | 48 | 0.110 |
Why?
|
| Gene Rearrangement | 1 | 2012 | 36 | 0.110 |
Why?
|
| Siblings | 1 | 2011 | 45 | 0.110 |
Why?
|
| Mice | 3 | 2021 | 9239 | 0.100 |
Why?
|
| Cognition | 1 | 2015 | 410 | 0.100 |
Why?
|
| Genetic Association Studies | 1 | 2011 | 99 | 0.100 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 1467 | 0.100 |
Why?
|
| Genotype | 2 | 2023 | 575 | 0.100 |
Why?
|
| Microfilament Proteins | 1 | 2012 | 110 | 0.100 |
Why?
|
| Animals | 6 | 2021 | 17863 | 0.100 |
Why?
|
| Neoplastic Stem Cells | 1 | 2012 | 187 | 0.100 |
Why?
|
| Neoplasm Proteins | 1 | 2012 | 248 | 0.090 |
Why?
|
| Protein Interaction Mapping | 1 | 2010 | 68 | 0.090 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2010 | 83 | 0.090 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2010 | 68 | 0.090 |
Why?
|
| Surveys and Questionnaires | 1 | 2017 | 2293 | 0.090 |
Why?
|
| Middle Aged | 3 | 2015 | 13531 | 0.090 |
Why?
|
| Adult | 3 | 2015 | 13416 | 0.090 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 646 | 0.090 |
Why?
|
| Cell Nucleus | 1 | 2012 | 565 | 0.080 |
Why?
|
| Base Sequence | 2 | 2023 | 1244 | 0.080 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 811 | 0.080 |
Why?
|
| Mental Disorders | 1 | 2014 | 669 | 0.070 |
Why?
|
| Genes, p53 | 1 | 2006 | 49 | 0.070 |
Why?
|
| United States | 1 | 2017 | 6433 | 0.070 |
Why?
|
| Software | 3 | 2015 | 324 | 0.070 |
Why?
|
| DNA, Mitochondrial | 1 | 2023 | 68 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2022 | 18 | 0.060 |
Why?
|
| Chromosome Disorders | 1 | 2022 | 15 | 0.060 |
Why?
|
| Chromosome Deletion | 1 | 2022 | 33 | 0.060 |
Why?
|
| Neoplasms | 1 | 2012 | 1079 | 0.050 |
Why?
|
| Single-Cell Analysis | 1 | 2022 | 73 | 0.050 |
Why?
|
| Adolescent | 1 | 2011 | 5331 | 0.050 |
Why?
|
| Sequence Analysis, RNA | 1 | 2022 | 134 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2023 | 631 | 0.050 |
Why?
|
| Systems Integration | 2 | 2010 | 27 | 0.050 |
Why?
|
| Transcriptome | 1 | 2022 | 282 | 0.040 |
Why?
|
| Mutation | 2 | 2023 | 2137 | 0.040 |
Why?
|
| Terminology as Topic | 2 | 2010 | 115 | 0.040 |
Why?
|
| Genes, Synthetic | 1 | 2018 | 5 | 0.040 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2018 | 13 | 0.040 |
Why?
|
| RecQ Helicases | 1 | 2018 | 9 | 0.040 |
Why?
|
| Open Reading Frames | 1 | 2018 | 78 | 0.040 |
Why?
|
| Biotechnology | 1 | 2018 | 36 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2018 | 113 | 0.040 |
Why?
|
| Conserved Sequence | 1 | 2018 | 167 | 0.040 |
Why?
|
| Mosaicism | 1 | 2017 | 24 | 0.040 |
Why?
|
| Zygote | 1 | 2017 | 44 | 0.040 |
Why?
|
| Aged | 1 | 2011 | 10998 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2018 | 451 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2018 | 527 | 0.040 |
Why?
|
| Repressor Proteins | 1 | 2018 | 307 | 0.040 |
Why?
|
| BALB 3T3 Cells | 1 | 2015 | 5 | 0.040 |
Why?
|
| Internet | 2 | 2010 | 464 | 0.030 |
Why?
|
| Lung Volume Measurements | 1 | 2015 | 12 | 0.030 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2015 | 60 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2015 | 62 | 0.030 |
Why?
|
| Serine | 1 | 2015 | 76 | 0.030 |
Why?
|
| Forced Expiratory Volume | 1 | 2015 | 69 | 0.030 |
Why?
|
| Protein Stability | 1 | 2015 | 80 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2015 | 111 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 2015 | 111 | 0.030 |
Why?
|
| Chaperonins | 1 | 2014 | 7 | 0.030 |
Why?
|
| Finland | 1 | 2014 | 20 | 0.030 |
Why?
|
| Proteolysis | 1 | 2015 | 114 | 0.030 |
Why?
|
| Likelihood Functions | 1 | 2014 | 69 | 0.030 |
Why?
|
| Biological Evolution | 1 | 2015 | 105 | 0.030 |
Why?
|
| Educational Status | 1 | 2015 | 270 | 0.030 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2018 | 408 | 0.030 |
Why?
|
| Transfection | 1 | 2015 | 612 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2015 | 789 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2015 | 489 | 0.030 |
Why?
|
| Quantitative Trait Loci | 1 | 2012 | 64 | 0.030 |
Why?
|
| Chromosome Breakpoints | 1 | 2012 | 5 | 0.030 |
Why?
|
| Filamins | 1 | 2012 | 6 | 0.030 |
Why?
|
| Glycolysis | 1 | 2012 | 49 | 0.030 |
Why?
|
| RNA Interference | 1 | 2015 | 575 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2012 | 54 | 0.030 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2012 | 99 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2012 | 60 | 0.030 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2012 | 95 | 0.030 |
Why?
|
| Zebrafish | 1 | 2014 | 300 | 0.030 |
Why?
|
| Pedigree | 1 | 2012 | 162 | 0.030 |
Why?
|
| Drug Resistance | 1 | 2012 | 79 | 0.030 |
Why?
|
| Anticonvulsants | 1 | 2012 | 84 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 181 | 0.030 |
Why?
|
| Seizures | 1 | 2012 | 92 | 0.030 |
Why?
|
| Exons | 1 | 2012 | 176 | 0.030 |
Why?
|
| Protein Binding | 1 | 2015 | 1474 | 0.030 |
Why?
|
| Computational Biology | 1 | 2012 | 296 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 464 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2012 | 615 | 0.020 |
Why?
|
| Genomics | 1 | 2012 | 278 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2010 | 139 | 0.020 |
Why?
|
| Information Dissemination | 1 | 2010 | 109 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 3161 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 1314 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2012 | 1196 | 0.020 |
Why?
|
| DNA | 1 | 2012 | 719 | 0.020 |
Why?
|
| Infant | 1 | 2012 | 1415 | 0.020 |
Why?
|
| Pregnancy | 1 | 2012 | 2143 | 0.020 |
Why?
|